Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Int J Mol Sci ; 25(9)2024 Apr 30.
Article in English | MEDLINE | ID: mdl-38732119

ABSTRACT

High-risk human papillomavirus (HR-HPV; HPV-16) and cigarette smoking are associated with cervical cancer (CC); however, the underlying mechanism(s) remain unclear. Additionally, the carcinogenic components of tobacco have been found in the cervical mucus of women smokers. Here, we determined the effects of cigarette smoke condensate (CSC; 3R4F) on human ectocervical cells (HPV-16 Ect/E6E7) exposed to CSC at various concentrations (10-6-100 µg/mL). We found CSC (10-3 or 10 µg/mL)-induced proliferation, enhanced migration, and histologic and electron microscopic changes consistent with EMT in ectocervical cells with a significant reduction in E-cadherin and an increase in the vimentin expression compared to controls at 72 h. There was increased phosphorylation of receptor tyrosine kinases (RTKs), including Eph receptors, FGFR, PDGFRA/B, and DDR2, with downstream Ras/MAPK/ERK1/2 activation and upregulation of common EMT-related genes, TGFB SNAI2, PDGFRB, and SMAD2. Our study demonstrated that CSC induces EMT in ectocervical cells with the upregulation of EMT-related genes, expression of protein biomarkers, and activation of RTKs that regulate TGFB expression, and other EMT-related genes. Understanding the molecular pathways and environmental factors that initiate EMT in ectocervical cells will help delineate molecular targets for intervention and define the role of EMT in the initiation and progression of cervical intraepithelial neoplasia and CC.


Subject(s)
Epithelial Cells , Epithelial-Mesenchymal Transition , Transforming Growth Factor beta , Humans , Epithelial-Mesenchymal Transition/drug effects , Female , Transforming Growth Factor beta/metabolism , Epithelial Cells/metabolism , Epithelial Cells/virology , Epithelial Cells/drug effects , Receptor Protein-Tyrosine Kinases/metabolism , Receptor Protein-Tyrosine Kinases/genetics , Cervix Uteri/pathology , Cervix Uteri/metabolism , Cervix Uteri/virology , Smoke/adverse effects , Papillomavirus Infections/metabolism , Papillomavirus Infections/virology , Papillomavirus Infections/pathology , Cell Proliferation/drug effects , Cell Movement/drug effects , Uterine Cervical Neoplasms/virology , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/metabolism , Uterine Cervical Neoplasms/etiology , Human papillomavirus 16/pathogenicity , Nicotiana/adverse effects , Human Papillomavirus Viruses
2.
Toxicol In Vitro ; 89: 105577, 2023 Jun.
Article in English | MEDLINE | ID: mdl-36849026

ABSTRACT

Perfluorooctanoic acid (PFOA) is tumorigenic in rats and mice and potentially tumorigenic in humans. Here, we studied long-term PFOA exposure with an in vitro transformation model using the rat liver epithelial cell, TRL 1215. Cells were cultured in 10 µM (T10), 50 µM (T50) and 100 µM (T100) PFOA for 38 weeks and compared to passage-matched control cells. T100 cells showed morphological changes, loss of cell contact inhibition, formation of multinucleated giant and spindle-shaped cells. T10, T50, and T100 cells showed increased LC50 values 20%, 29% to 35% above control with acute PFOA treatment, indicating a resistance to PFOA toxicity. PFOA-treated cells showed increases in Matrix metalloproteinase-9 secretion, cell migration, and developed more and larger colonies in soft agar. Microarray data showed Myc pathway activation at T50 and T100, associating Myc upregulation with PFOA-induced morphological transformation. Western blot confirmed that PFOA produced significant increases in c-MYC protein expression in a time- and concentration-related manner. Tumor invasion indicators MMP-2 and MMP-9, cell cycle regulator cyclin D1, and oxidative stress protein GST were all significantly overexpressed in T100 cells. Taken together, chronic in vitro PFOA exposure produced multiple cell characteristics of malignant progression and differential gene expression changes suggestive of rat liver cell transformation.


Subject(s)
Fluorocarbons , Hepatocytes , Humans , Rats , Mice , Animals , Caprylates/toxicity , Fluorocarbons/toxicity , Cell Transformation, Neoplastic , Liver
3.
Biomedicines ; 10(4)2022 Apr 16.
Article in English | MEDLINE | ID: mdl-35453667

ABSTRACT

Cadmium (Cd) is one of the most prevalent environmental heavy metal contaminants and is considered an endocrine disruptor and carcinogen. In women with uterine fibroids, there is a correlation between blood Cd levels and fibroid tumor size. In this study, fibroid cells were exposed to 10 µM CdCl2 for 6 months and a fast-growing Cd-Resistant Leiomyoma culture, termed CR-LM6, was recovered. To characterize the morphological and mechanodynamic features of uterine fibroid cells associated with prolonged Cd exposure, we conducted time lapse imaging using a Zeiss confocal microscope and analyzed data by Imaris and RStudio. Our experiments recorded more than 64,000 trackable nuclear surface objects, with each having multiple parameters such as nuclear size and shape, speed, location, orientation, track length, and track straightness. Quantitative analysis revealed that prolonged Cd exposure significantly altered cell migration behavior, such as increased track length and reduced track straightness. Cd exposure also significantly increased the heterogeneity in nuclear size. Additionally, Cd significantly increased the median and variance of instantaneous speed, indicating that Cd exposure results in higher speed and greater variation in motility. Profiling of mRNA by NanoString analysis and Ingenuity Pathway Analysis (IPA) strongly suggested that the direction of gene expression changes due to Cd exposure enhanced cell movement and invasion. The altered expression of extracellular matrix (ECM) genes such as collagens, matrix metallopeptidases (MMPs), secreted phosphoprotein 1 (SPP1), which are important for migration contact guidance, may be responsible for the greater heterogeneity. The significantly increased heterogeneity of nuclear size, speed, and altered migration patterns may be a prerequisite for fibroid cells to attain characteristics favorable for cancer progression, invasion, and metastasis.

4.
FASEB J ; 36(2): e22101, 2022 02.
Article in English | MEDLINE | ID: mdl-35032343

ABSTRACT

Tetrabromobisphenol A (TBBPA), a derivative of BPA, is a ubiquitous environmental contaminant with weak estrogenic properties. In women, uterine fibroids are highly prevalent estrogen-responsive tumors often with excessive accumulation of extracellular matrix (ECM) and may be the target of environmental estrogens. We have found that BPA has profibrotic effects in vitro, in addition to previous reports of the in vivo fibrotic effects of BPA in mouse uterus. However, the role of TBBPA in fibrosis is unclear. To investigate the effects of TBBPA on uterine fibrosis, we developed a 3D human uterine leiomyoma (ht-UtLM) spheroid culture model. Cell proliferation was evaluated in 3D ht-UtLM spheroids following TBBPA (10-6 -200 µM) administration at 48 h. Fibrosis was assessed using a Masson's Trichrome stain and light microscopy at 7 days of TBBPA (10-3  µM) treatment. Differential expression of ECM and fibrosis genes were determined using RT² Profiler™ PCR arrays. Network and pathway analyses were conducted using Ingenuity Pathway Analysis. The activation of pathway proteins was analyzed by a transforming growth factor-beta (TGFB) protein array. We found that TBBPA increased cell proliferation and promoted fibrosis in 3D ht-UtLM spheroids with increased deposition of collagens. TBBPA upregulated the expression of profibrotic genes and corresponding proteins associated with the TGFB pathway. TBBPA activated TGFB signaling through phosphorylation of TGFBR1 and downstream effectors-small mothers against decapentaplegic -2 and -3 proteins (SMAD2 and SMAD3). The 3D ht-UtLM spheroid model is an effective system for studying environmental agents on human uterine fibrosis. TBBPA can promote fibrosis in uterine fibroid through TGFB/SMAD signaling.


Subject(s)
Fibrosis/chemically induced , Fibrosis/metabolism , Leiomyoma/chemically induced , Polybrominated Biphenyls/administration & dosage , Transforming Growth Factor beta/metabolism , Uterine Neoplasms/chemically induced , Uterine Neoplasms/metabolism , Cell Culture Techniques, Three Dimensional/methods , Cell Proliferation/drug effects , Estrogens/metabolism , Extracellular Matrix/drug effects , Extracellular Matrix/metabolism , Female , Humans , Leiomyoma/metabolism , Phosphorylation/drug effects , Signal Transduction/drug effects
5.
Nutrients ; 13(9)2021 Aug 30.
Article in English | MEDLINE | ID: mdl-34578926

ABSTRACT

Advanced research in recent years has revealed the important role of nutrients in the protection of women's health and in the prevention of women's diseases. Genistein is a phytoestrogen that belongs to a class of compounds known as isoflavones, which structurally resemble endogenous estrogen. Genistein is most often consumed by humans via soybeans or soya products and is, as an auxiliary medicinal, used to treat women's diseases. In this review, we focused on analyzing the geographic distribution of soybean and soya product consumption, global serum concentrations of genistein, and its metabolism and bioactivity. We also explored genistein's dual effects in women's health through gathering, evaluating, and summarizing evidence from current in vivo and in vitro studies, clinical observations, and epidemiological surveys. The dose-dependent effects of genistein, especially when considering its metabolites and factors that vary by individuals, indicate that consumption of genistein may contribute to beneficial effects in women's health and disease prevention and treatment. However, consumption and exposure levels are nuanced because adverse effects have been observed at lower concentrations in in vitro models. Therefore, this points to the duplicity of genistein as a possible therapeutic agent in some instances and as an endocrine disruptor in others.


Subject(s)
Endocrine Disruptors/pharmacology , Genistein/pharmacology , Phytoestrogens/pharmacology , Women's Health , Female , Humans
6.
FASEB J ; 35(8): e21738, 2021 08.
Article in English | MEDLINE | ID: mdl-34245615

ABSTRACT

The heavy metal Cadmium (Cd), a widespread environmental contaminant, poses serious hazards to human health and is considered a metallohormone and carcinogen. In women with uterine fibroids, there is a significant association between blood Cd levels and increased fibroid tumor size. The aim of this study was to determine if benign human uterine leiomyoma (fibroid) cells could be malignantly transformed in vitro by continuous Cd exposure and, if so, explore a molecular mechanism by which this could occur. We found when fibroid cells were exposed to 10 µM CdCl2 for 8 weeks, a robust and fast-growing Cd-Resistant Leiomyoma (CR-LM) cell culture was established. The CR-LM cells formed viable colonies in soft agar and had increased cytoplasmic glycogen aggregates, enhanced cell motility, a higher percentage of cells in G2/M phase, and increased expression of the proliferation marker Ki-67. NanoString analysis showed downregulation of genes encoding for extracellular matrix (ECM) components, such as collagens, fibronectins, laminins, and SLRP family proteins, whereas genes involved in ECM degradation (MMP1, MMP3, and MMP10) were significantly upregulated. A volcano plot showed that the top differentially genes favored cancer progression. Functional analysis by ingenuity pathway analysis predicted a significant inhibition of TGFB1 signaling, leading to enhanced proliferation and attenuated fibrosis. Prolonged Cd exposure altered phenotypic characteristics and dysregulated genes in fibroid cells predicative of progression towards a cancer phenotype. Therefore, continuous Cd exposure alters the benign characteristics of fibroid cells in vitro, and Cd exposure could possibly pose a health hazard for women with uterine fibroids.


Subject(s)
Cadmium/toxicity , Extracellular Matrix/metabolism , Leiomyoma/metabolism , Signal Transduction/drug effects , Transforming Growth Factor beta/metabolism , Uterine Neoplasms/metabolism , Cell Line, Tumor , Female , Humans , Leiomyoma/pathology , Uterine Neoplasms/pathology
7.
Arch Toxicol ; 95(6): 1995-2006, 2021 06.
Article in English | MEDLINE | ID: mdl-33818655

ABSTRACT

Cadmium (Cd) is a toxic metal reported to act as an estrogen "mimic" in the rat uterus and in vitro. We have reported that Cd stimulates proliferation of estrogen-responsive human uterine leiomyoma (ht-UtLM; fibroid) cells through nongenomic signaling involving the G protein-coupled estrogen receptor (GPER), with activation of epidermal growth factor receptor (EGFR) and mitogen-activated protein kinase (pMAPK44/42). In this study, we explored Cd-induced mechanisms downstream of MAPK and whether Cd could stimulate phosphorylation of Histone H3 at serine 10 (H3Ser10ph) through activated Aurora B kinase (pAurora B), a kinase important in activation of histone H3 at serine 10 during mitosis, and if this occurs via Fork head box M1 (FOXM1) and cyclin D1 immediately downstream of MAPK. We found that Cd increased proliferating cell nuclear antigen (PCNA) and H3Ser10ph expression by immunofluorescence, and that H3ser10ph and pAurora B were coexpressed along the metaphase plate in ht-UtLM cells. In addition, Cd-exposed cells showed higher expression of pMAPK44/42, FOXM1, pAurora B, H3ser10ph, and Cyclin D1 by western blotting. Immunoprecipitation and proximity ligation assays further indicated an association between FOXM1 and Cyclin D1 in Cd-exposed cells. These effects were attenuated by MAPK kinase (MEK1/2) inhibitor. In summary, Cd-induced proliferation of ht-UtLM cells occurred through activation of Histone H3 and Aurora B via FOXM1/Cyclin D1 interactions downstream of MAPK. This provides a molecular mechanism of how Cd acts as an "estrogen mimic" resulting in mitosis in hormonally responsive cells.


Subject(s)
Cadmium/toxicity , Leiomyoma/metabolism , Mitosis/drug effects , Uterine Neoplasms/metabolism , Aurora Kinase B/metabolism , Cell Proliferation/drug effects , Cells, Cultured , Cyclin D1/metabolism , Female , Forkhead Box Protein M1/metabolism , Histones/metabolism , Humans , Mitogen-Activated Protein Kinases/metabolism , Receptors, Estrogen/drug effects , Receptors, Estrogen/metabolism , Receptors, G-Protein-Coupled/drug effects , Receptors, G-Protein-Coupled/metabolism , Signal Transduction/drug effects
8.
Arch Toxicol ; 93(10): 2773-2785, 2019 10.
Article in English | MEDLINE | ID: mdl-31468104

ABSTRACT

Cadmium (Cd) is a ubiquitous environmental metal that is reported to be a "metalloestrogen." Uterine leiomyomas (fibroids) are estrogen-responsive gynecologic neoplasms that can be the target of xenoestrogens. Previous epidemiology studies have suggested Cd may be associated with fibroids. We have shown that Cd can stimulate proliferation of human uterine leiomyoma (ht-UtLM) cells, but not through classical estrogen receptor (ER) binding. Whether nongenomic ER pathways are involved in Cd-induced proliferation is unknown. In the present study, by evaluating G protein-coupled estrogen receptor (GPER), ERα36, and phospho-epidermal growth factor receptor (EGFR) expression in human tissues, we found that GPER, ERα36 and phospho-EGFR were all highly expressed in fibroids compared to patient-matched myometrial tissues. In ht-UtLM cells, cell proliferation was increased by low doses of Cd (0.1 µM and 10 µM), and this effect could be inhibited by GPER-specific antagonist (G15) pretreatment, or silencing (si) GPER, but not by siERα36. Cd-activated MAPK was dependent on GPER/EGFR transactivation, through significantly increased phospho-Src, matrix metalloproteinase-2 (MMP2) and MMP9, and heparin-binding EGF-like growth factor (HB-EGF) expression/activation. Also, phospho-Src could interact directly to phosphorylate EGFR. Overall, Cd-induced proliferation of human fibroid cells was through a nongenomic GPER/p-src/EGFR/MAPK signaling pathway that did not directly involve ERα36. This suggests that Cd may be a risk factor for uterine fibroids through cross talk between hormone and growth factor receptor pathways.


Subject(s)
Cadmium Chloride/toxicity , Cell Proliferation/drug effects , Leiomyoma/pathology , Uterine Neoplasms/pathology , Adult , Cadmium Chloride/administration & dosage , Dose-Response Relationship, Drug , ErbB Receptors/genetics , Estrogen Receptor alpha/genetics , Female , Gene Expression Regulation , Gene Silencing , Humans , Leiomyoma/chemically induced , Leiomyoma/genetics , Middle Aged , Receptors, Estrogen/genetics , Receptors, G-Protein-Coupled/genetics , Uterine Neoplasms/chemically induced , Uterine Neoplasms/genetics
9.
Mol Cell Endocrinol ; 484: 59-68, 2019 03 15.
Article in English | MEDLINE | ID: mdl-30615907

ABSTRACT

The role of ERα36 in regulating BPA's effects and its potential as a risk factor for human uterine fibroids were evaluated. BPA at low concentrations (10-6 µM - 10 µM) increased proliferation by facilitating progression of hormonally regulated, immortalized human uterine leiomyoma (ht-UtLM; fibroid) cells from G0-G1 into S phase of the cell cycle; whereas, higher concentrations (100 µM-200 µM) decreased growth. BPA upregulated ERα36 gene and protein expression, and induced increased SOS1 and Grb2 protein expression, both of which are mediators of the MAPKp44/42/ERK1/2 pathway. EGFR (pEGFR), Ras, and MAPKp44/42 were phosphorylated with concurrent Src activation in ht-UtLM cells within 10 min of BPA exposure. BPA enhanced colocalization of phosphorylated Src (pSrc) to ERα36 and coimmunoprecipitation of pSrc with pEGFR. Silencing ERα36 with siERα36 abolished the above effects. BPA induced proliferation in ht-UtLM cells through membrane-associated ERα36 with activation of Src, EGFR, Ras, and MAPK nongenomic signaling pathways.


Subject(s)
Benzhydryl Compounds/adverse effects , Estrogen Receptor alpha/genetics , Estrogen Receptor alpha/metabolism , Leiomyoma/metabolism , Phenols/adverse effects , Benzhydryl Compounds/pharmacology , Cell Cycle/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Female , GRB2 Adaptor Protein/metabolism , Gene Expression Regulation/drug effects , Humans , Leiomyoma/chemically induced , Leiomyoma/genetics , Phenols/pharmacology , Phosphorylation , SOS1 Protein/metabolism , Signal Transduction/drug effects , Up-Regulation
10.
PLoS One ; 12(10): e0186078, 2017.
Article in English | MEDLINE | ID: mdl-29020039

ABSTRACT

ERα36 is a naturally occurring, membrane-associated, isoform of estrogen receptor α. The expression of ERα36 is due to alternative splicing and different promoter usage. ERα36 is a dominant-negative effector of ERα66-mediated transactivational activities and has the potential to trigger membrane-initiated mitogenic, nongenomic, estrogen signaling; however, the subcellular localization of ERα36 remains controversial. To determine the cellular localization of ERα36 in estrogen-responsive human uterine smooth muscle (ht-UtSMC) and leiomyoma (fibroid; ht-UtLM) cells, we conducted systematic confocal microscopy and subcellular fractionation analysis using ERα36 antibodies. With Image J colocalizaton analysis plugin, confocal images were analyzed to obtain a Pearson's Correlation Coefficient (PCC) to quantify signal colocalization of ERα36 with mitochondrial, endoplasmic reticulum, and cytoskeletal components in both cell lines. When cells were double-stained with an ERα36 antibody and a mitochondrial-specific dye, MitoTracker, the PCC for the two channel signals were both greater than 0.75, indicating strong correlation between ERα36 and mitochondrial signals in the two cell lines. A blocking peptide competition assay confirmed that the mitochondria-associated ERα36 signal detected by confocal analysis was specific for ERα36. In contrast, confocal images double-stained with an ERα36 antibody and endoplasmic reticulum or cytoskeletal markers, had PCCs that were all less than 0.4, indicating no or very weak signal correlation. Fractionation studies showed that ERα36 existed predominantly in membrane fractions, with minimal or undetected amounts in the cytosol, nuclear, chromatin, and cytoskeletal fractions. With isolated mitochondrial preparations, we confirmed that a known mitochondrial protein, prohibitin, was present in mitochondria, and by co-immunoprecipitation analysis that ERα36 was associated with prohibitin in ht-UtLM cells. The distinctive colocalization pattern of ERα36 with mitochondria in ht-UtSMC and ht-UtLM cells, and the association of ERα36 with a mitochondrial-specific protein suggest that ERα36 is localized primarily in mitochondria and may play a pivotal role in non-genomic signaling and mitochondrial functions.


Subject(s)
Estrogen Receptor alpha/metabolism , Leiomyoma/metabolism , Mitochondria/metabolism , Myocytes, Smooth Muscle/metabolism , Uterus/pathology , Actins/metabolism , Cell Line, Tumor , Endoplasmic Reticulum/metabolism , Estrogen Receptor alpha/chemistry , Female , Humans , Intracellular Membranes/metabolism , Leiomyoma/pathology , Myocytes, Smooth Muscle/pathology , Peptides/metabolism , Prohibitins , Protein Binding , Protein Domains , Protein Transport , Repressor Proteins/metabolism , Subcellular Fractions/metabolism
11.
Cell Commun Signal ; 14(1): 18, 2016 08 31.
Article in English | MEDLINE | ID: mdl-27582276

ABSTRACT

BACKGROUND: The phytoestrogen, genistein at low doses nongenomically activates mitogen-activated protein kinase p44/42 (MAPKp44/42) via estrogen receptor alpha (ERα) leading to proliferation of human uterine leiomyoma cells. In this study, we evaluated if MAPKp44/42 could activate downstream effectors such as mitogen- and stress-activated protein kinase 1 (MSK1), which could then epigenetically modify histone H3 by phosphorylation following a low dose (1 µg/ml) of genistein. RESULTS: Using hormone-responsive immortalized human uterine leiomyoma (ht-UtLM) cells, we found that genistein activated MAPKp44/42 and MSK1, and also increased phosphorylation of histone H3 at serine10 (H3S10ph) in ht-UtLM cells. Colocalization of phosphorylated MSK1 and H3S10ph was evident by confocal microscopy in ht-UtLM cells (r = 0.8533). Phosphorylation of both MSK1and H3S10ph was abrogated by PD98059 (PD), a MEK1 kinase inhibitor, thereby supporting genistein's activation of MSK1 and Histone H3 was downstream of MAPKp44/42. In proliferative (estrogenic) phase human uterine fibroid tissues, phosphorylated MSK1 and H3S10ph showed increased immunoexpression compared to normal myometrial tissues, similar to results observed in in vitro studies following low-dose genistein administration. Real-time RT-PCR arrays showed induction of growth-related transcription factor genes, EGR1, Elk1, ID1, and MYB (cMyb) with confirmation by western blot, downstream of MAPK in response to low-dose genistein in ht-UtLM cells. Additionally, genistein induced associations of promoter regions of the above transcription factors with H3S10ph as evidenced by Chromatin Immunoprecipitation (ChIP) assays, which were inhibited by PD. Therefore, genistein epigenetically modified histone H3 by phosphorylation of serine 10, which was regulated by MSK1 and MAPK activation. CONCLUSION: Histone H3 phosphorylation possibly represents a mechanism whereby increased transcriptional activation occurs following low-dose genistein exposure.


Subject(s)
Antineoplastic Agents/pharmacology , Epigenesis, Genetic , Genistein/pharmacology , MAP Kinase Signaling System/drug effects , Promoter Regions, Genetic , Ribosomal Protein S6 Kinases, 90-kDa/metabolism , Transcription Factors/metabolism , Cell Line, Tumor , Histones/metabolism , Humans , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Phosphorylation , Protein Processing, Post-Translational , Transcription Factors/genetics , Transcriptional Activation/drug effects
12.
Genes Chromosomes Cancer ; 55(4): 397-406, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26799600

ABSTRACT

Histone phosphorylation has a profound impact on epigenetic regulation of gene expression, chromosome condensation and segregation, and maintenance of genome integrity. Histone H3 Serine 10 is evolutionally conserved and heavily phosphorylated during mitosis. To examine Histone H3 Serine 10 phosphorylation (H3S10ph) dynamics in mitosis, we applied immunogold labeling and confocal microscopy to visualize H3S10ph expression in MCF-7 cells. Confocal observations showed that MCF-7 cells had abundant H3S10ph expression in prophase and metaphase. In anaphase, the H3S10ph expression was significantly decreased and displayed only sparsely localized staining that mainly associated with the chromatid tips. We showed that immunogold bead density distribution followed the H3S10ph expression patterns observed in confocal analysis. At a higher magnification in metaphase, the immunogold beads were readily visible and the bead distribution along the condensed chromosomes was distinctive, indicating the specificity and reliability of the immunogold staining procedure. In anaphase, the beads were found to distribute focally in specific regions of chromatids, reinforcing the confocal observations of differential H3 phosphorylation. To our knowledge, this is the first report to show the specific H3S10ph expression with an immunogold technique and transmission electron microscopy. Additionally, with confocal microscopy, we analyzed H3S10ph expression in an immortalized cell line derived from benign uterine smooth muscle tumor cells. H3S10ph epitope was expressed more abundantly during anaphase in the benign tumor cells, and there was no dramatic differential expression within the condensed chromatid clusters as observed in MCF-7 cells. The differences in H3S10ph expression pattern and dynamics may contribute to the differential proliferative potential between benign tumor cells and MCF-7 cells.


Subject(s)
Histones/metabolism , Microscopy, Confocal/methods , Microscopy, Electron, Transmission/methods , Microscopy, Immunoelectron/methods , Mitosis , Serine/metabolism , Cell Proliferation , Chromatin/metabolism , Epitopes/biosynthesis , Humans , MCF-7 Cells , Phosphorylation
13.
PLoS One ; 7(8): e43077, 2012.
Article in English | MEDLINE | ID: mdl-22912791

ABSTRACT

Multivalency of targeting ligands provides significantly increased binding strength towards their molecular targets. Here, we report the development of a novel heptameric targeting system, with general applications, constructed by fusing a target-binding domain with the heptamerization domain of the Archaeal RNA binding protein Sm1 through a flexible hinge peptide. The previously reported affibody molecules against EGFR and HER2, Z(EGFR) and Z(HER2), were used as target binding moieties. The fusion molecules were highly expressed in E. coli as soluble proteins and efficiently self-assembled into multimeric targeting ligands with the heptamer as the predominant form. We demonstrated that the heptameric molecules were resistant to protease-mediated digestion or heat- and SDS-induced denaturation. Surface plasmon resonance (SPR) analysis showed that both heptameric Z(EGFR) and Z(HER2) ligands have a significantly enhanced binding strength to their target receptors with a nearly 100 to 1000 fold increase relative to the monomeric ligands. Cellular binding assays showed that heptameric ligands maintained their target-binding specificities similar to the monomeric forms towards their respective receptor. The non-toxic property of each heptameric ligand was demonstrated by the cell proliferation assay. In general,, the heptamerization strategy we describe here could be applied to the facile and efficient engineering of other protein domain- or short peptide-based affinity molecules to acquire significantly improved target-binding strengths with potential applications in the targeted delivery of various imaging or therapeutic agents..


Subject(s)
Drug Delivery Systems/methods , ErbB Receptors/metabolism , Ligands , RNA, Archaeal/metabolism , Receptor, ErbB-2/metabolism , Amino Acid Sequence , Base Sequence , Circular Dichroism , Flow Cytometry , Fluorescein-5-isothiocyanate , Humans , Jurkat Cells , MCF-7 Cells , Molecular Sequence Data , Sequence Analysis, DNA , Ultracentrifugation
14.
Int J Parasitol ; 32(1): 65-72, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11796123

ABSTRACT

Parasitism by the soybean cyst nematode, Heterodera glycines, has become one of the major limiting factors in soybean production world-wide. A partial HG-gcy-1 cDNA clone was obtained by screening a H. glycines cDNA library with a probe derived from the HG-gcy1 genomic sequence, and HG-gcy-1 full-length cDNA was obtained by nested PCR and 5' rapid amplification of cDNA ends (5' RACE). Two additional, full-length guanylyl cyclase cDNA clones from H. glycines, named HG-gcy-2 and HG-gcy-3, were recovered directly by screening the H. glycines cDNA library with a probe derived from sequence of the HG-gcy-1 catalytic domain. The encoded proteins of all three HG-gcy genes had an extracellular ligand-binding domain, a single membrane-spanning domain, an intracellular protein kinase-like domain, and a guanylyl cyclase catalytic domain. The three HG-GCY proteins had conserved cysteine residues to form disulfide bridges within the extracellular domain similar to the predicted ligand-binding domains of other known membrane-bound guanylyl cyclases. mRNA in situ hybridisation detected the expression of HG-gcy-1 and HG-gcy-2 transcripts in specific and different sensory neurons within H. glycines specimens. HG-gcy-3 transcripts were not localised in H. glycines specimens by in situ hybridisation. The discovery of the three guanylyl cyclase genes in H. glycines is the first of its kind in a plant-parasitic nematode and may be representative of a conserved gene family used for chemosensory recognition in parasitic nematodes.


Subject(s)
DNA, Helminth/genetics , Glycine max/parasitology , Guanylate Cyclase/genetics , Nematoda/enzymology , Amino Acid Sequence , Animals , Base Sequence , DNA, Helminth/chemistry , DNA, Helminth/isolation & purification , Guanylate Cyclase/chemistry , In Situ Hybridization , Isoenzymes/chemistry , Isoenzymes/genetics , Molecular Sequence Data , Nematoda/genetics , Polymerase Chain Reaction , RNA, Messenger/chemistry , Sequence Homology, Amino Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...